Literature DB >> 11833089

Construction of HCV-core gene vector and its expression in cholangiocarcinoma.

Xiao-Fang Liu1, Sheng-Quan Zou, Fa-Zu Qiu.   

Abstract

AIM: To establish an experimental model for exploring the role of hepatitis C virus (HCV) in the development of cholangiocarcinoma.
METHODS: Recombinant plasmid of HCV-core gene was constructed with molecular cloning technique and transfected into QBC939 cells with lipofection.After it was selected with G418, resistant colonies were obtained. The colonies were analysed by immunocytochemistry and Western blotting. The morphology was observed under transmission electron microscope(TEM) and microscope.
RESULTS: The recombinant plasmid was proved to carry the target gene by PCR and restriction enzymed mapping. Moreover, it could express HCV-C protein efficiently in QBC939 cells. The HCV-like particles were found in the cytoplasm by electron microscope, which were spherical with a diameter of 50 nm-80 nm possessing outer membrane. The transfected cells had lower differentiation and higher malignant degree under microscope.
CONCLUSION: Because HCV-core gene could express steadily in cholangiocarcinoma cells,the transfected tumor cells(QBC939-HCVC) could be used to study the effect of HCV in the development of cholangiocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11833089      PMCID: PMC4656605          DOI: 10.3748/wjg.v8.i1.135

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  38 in total

1.  Effect of 5-Aza-2'-deoxycytidine on the P16 tumor suppressor gene in hepatocellular carcinoma cell line HepG2.

Authors:  L H Liu; W H Xiao; W W Liu
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

2.  Extraction and purification of TGFbeta and its effect on the induction of apoptosis of hepatocytes.

Authors:  X H Si; L J Yang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

3.  Activation of nuclear factor kappaB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis.

Authors:  D I Tai; S L Tsai; Y M Chen; Y L Chuang; C Y Peng; I S Sheen; C T Yeh; K S Chang; S N Huang; G C Kuo; Y F Liaw
Journal:  Hepatology       Date:  2000-03       Impact factor: 17.425

4.  Steatosis and bile duct damage in chronic hepatitis C: distribution and relationships in a group of Northern Italian patients.

Authors:  E Giannini; P Ceppa; F Botta; A Fasoli; P Romagnoli; E Cresta; V Venturino; D Risso; G Celle; R Testa
Journal:  Liver       Date:  1999-10

5.  Cloning and expression of core gene cDNA of Chinese hepatitis C virus in cosmid pTM3.

Authors:  Rong-Long Jiang; Qiao-Sheng Lu; Kang-Xian Luo
Journal:  World J Gastroenterol       Date:  2000-04       Impact factor: 5.742

6.  Hepatitis C virus may infect extrahepatic tissues in patients with hepatitis C.

Authors:  Fu-Ming Yan; An-Shen Chen; Fei Hao; Xi-Ping Zhao; Chang-Hai Gu; Li-Bin Zhao; Dong-Liang Yang; Lian-Jie Hao
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

7.  Inhibition of tumor necrosis factor (TNF-alpha)-mediated apoptosis by hepatitis C virus core protein.

Authors:  R B Ray; K Meyer; R Steele; A Shrivastava; B B Aggarwal; R Ray
Journal:  J Biol Chem       Date:  1998-01-23       Impact factor: 5.157

Review 8.  A 67-year-old man with hepatitis C virus infection and a liver tumor.

Authors:  A Suriawinata; K Ivanov; M Ben Haim; M E Schwartz
Journal:  Semin Liver Dis       Date:  2000       Impact factor: 6.115

9.  Detection of hepatitis C virus RNA in peripheral blood mononuclear cells of infected patients by in situ hybridization.

Authors:  J Moldvay; P Deny; S Pol; C Brechot; E Lamas
Journal:  Blood       Date:  1994-01-01       Impact factor: 22.113

10.  Susceptibility of human T-lymphotropic virus type I infected cell line MT-2 to hepatitis C virus infection.

Authors:  N Kato; T Nakazawa; T Mizutani; K Shimotohno
Journal:  Biochem Biophys Res Commun       Date:  1995-01-26       Impact factor: 3.575

View more
  4 in total

1.  Activity of HDV ribozymes to trans-cleave HCV RNA.

Authors:  Yue-Cheng Yu; Qing Mao; Chang-Hai Gu; Qi-Fen Li; Yu-Ming Wang
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

2.  Establishment of a transgenic cell line stably expressing human cytochrome P450 2C18 and identification of a CYP2C18 clone with exon 5 missing.

Authors:  Jian Zhu-Ge; Ying-Nian Yu; Yu-Li Qian; Xin Li
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

3.  Cloning of cytochrome P-450 2C9 cDNA from human liver and its expression in CHL cells.

Authors:  Ge-Jian Zhu; Ying-Nian Yu; Xin Li; Yu-Li Qian
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

4.  Anti-tumor effect of pEgr-IFNgamma gene-radiotherapy in B16 melanoma-bearing mice.

Authors:  Cong-Mei Wu; Xiu-Yi Li; Tian-Hua Huang
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.